Subtype
Glioma
CI-CAN-00000935Explore in graph →
Non-malignant787 active trials5 approved drugs147 evidence items
Loading cancer entity…
Subtype
CI-CAN-00000935Explore in graph →
Clinical trials
2,804 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02285959 | Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme | unknown | Phase 1 | 30 | Global Neurosciences InstituteOTHER | 1 | Aug 10, 2022 | clinicaltrials |
| NCT05459441 | Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases | unknown | Early Phase 1 | 30 | Shanghai Pudong HospitalOTHER | 1 |
| Jul 15, 2022 |
| clinicaltrials |
| NCT05447195 | Phase 2 Study of CAN008 in Subjects With GBM | unknown | Phase 2 | 117 | CANbridge Life Sciences Ltd.INDUSTRY | 1 | Jul 12, 2022 | clinicaltrials |
| NCT05099068 | Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)(PLANET) | unknown | N/A | 500 | Centre Leon BerardOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT03243461 | International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)(HIT-HGG-2013) | unknown | Phase 3 | 167 | University of GöttingenOTHER | 1 | Jun 6, 2022 | clinicaltrials |
| NCT05399524 | Functional and Ultrasound Guided Resection of Glioblastoma(FUTURE-GB) | unknown | N/A | 357 | University of OxfordOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT00045968 | Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer(GBM) | unknown | Phase 3 | 348 | Northwest BiotherapeuticsINDUSTRY | 4 | May 18, 2022 | clinicaltrials |
| NCT05366062 | ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab | unknown | Phase 2 | 28 | Epitopoietic Research CorporationINDUSTRY | 1 | May 13, 2022 | clinicaltrials |
| NCT00075387 | Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors | unknown | Phase 2 | 48 | OHSU Knight Cancer InstituteOTHER | 1 | May 3, 2022 | clinicaltrials |
| NCT05333588 | The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme. | unknown | Early Phase 1 | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Apr 19, 2022 | clinicaltrials |
| NCT04738110 | Post-operative Imaging in High Grade Glioma: is Management Influenced?(PIGMI) | unknown | — | 150 | King's College Hospital NHS TrustOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT04539431 | Glioma Brain Tumours - E12513 - SensiScreen Glioma | unknown | — | 220 | Ente Ospedaliero Cantonale, BellinzonaOTHER | 1 | Jan 24, 2022 | clinicaltrials |
| NCT02796261 | Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients(STELLAR) | unknown | Phase 3 | 343 | Orbus Therapeutics, Inc.INDUSTRY | 8 | Jan 21, 2022 | clinicaltrials |
| NCT05201326 | Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Jan 21, 2022 | clinicaltrials |
| NCT05188534 | ZOOMit-fMRI Identifies Language Functional Cortex | unknown | — | 60 | Beijing Neurosurgical InstituteOTHER | 1 | Jan 12, 2022 | clinicaltrials |
| NCT05143775 | Strategic Intervention on Preserving Language Function During Awake Craniotomy | unknown | N/A | 60 | Beijing Neurosurgical InstituteOTHER | 1 | Jan 3, 2022 | clinicaltrials |
| NCT05143788 | Strategic Intervention on Preserving Motor Function During Awake Craniotomy | unknown | N/A | 60 | Beijing Neurosurgical InstituteOTHER | 0 | Dec 20, 2021 | clinicaltrials |
| NCT03400917 | Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma | unknown | Phase 2 | 55 | Aivita Biomedical, Inc.INDUSTRY | 1 | Dec 16, 2021 | clinicaltrials |
| NCT04888611 | Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma | unknown | Phase 2 | 40 | Huashan HospitalOTHER | 1 | Nov 30, 2021 | clinicaltrials |
| NCT05131711 | Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)(CSREIG) | unknown | Phase 1 / Phase 2 | 60 | Beijing Tiantan HospitalOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT05131763 | NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors | unknown | Phase 1 | 3 | Fudan UniversityOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT05108012 | Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients | unknown | Phase 1 | 5 | Royan InstituteOTHER_GOV | 1 | Nov 22, 2021 | clinicaltrials |
| NCT03932981 | First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of Progression(TEMOTRAD01) | unknown | Phase 2 | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT04407039 | Establishment and Evaluation of Multimodal Image Recognition System of Glioma Based on Deep Learning | unknown | — | 350 | Tao XinOTHER | 0 | Sep 9, 2021 | clinicaltrials |
| NCT05033587 | Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. | unknown | Phase 2 | 28 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT03347097 | Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme | unknown | Early Phase 1 | 40 | Huashan HospitalOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT05019196 | fMRI Study of Functional Reorganization in Glioma Patients | unknown | — | 100 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Aug 24, 2021 | clinicaltrials |
| NCT04970615 | Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models(IMAGE-3D) | unknown | — | 60 | Sümeyye SezerOTHER | 1 | Jul 21, 2021 | clinicaltrials |
| NCT04953468 | Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema Promotes Glioma Invasion | unknown | — | 130 | Peking University Third HospitalOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT04856852 | Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma(IBCNG) | unknown | N/A | 84 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Jun 29, 2021 | clinicaltrials |
| NCT04943718 | Personalized Vaccine for Patients With Recurrent Malignant Glioma | unknown | Phase 1 | 10 | Xuanwu Hospital, BeijingOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT03423992 | Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas | unknown | Phase 1 | 100 | Xuanwu Hospital, BeijingOTHER | 1 | Jun 15, 2021 | clinicaltrials |
| NCT04902586 | Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma(ECTG001) | unknown | N/A | 30 | Zhongnan HospitalOTHER | 1 | May 26, 2021 | clinicaltrials |
| NCT03008148 | Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM | unknown | Phase 2 / Phase 3 | 288 | Johnpro Biotech, Inc.INDUSTRY | 1 | May 11, 2021 | clinicaltrials |
| NCT04874506 | MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM) | unknown | Phase 2 | 55 | Matrix Biomed, Inc.INDUSTRY | 1 | May 5, 2021 | clinicaltrials |
| NCT03025893 | A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme(STELLAR) | unknown | Phase 2 / Phase 3 | 100 | Amsterdam UMC, location VUmcOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT04843085 | Proteomic Characterization of Aggressive Oligodendrogliomas(PROGLIO) | unknown | — | 120 | Hospices Civils de LyonOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT04829097 | Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma | unknown | Phase 3 | 80 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Apr 2, 2021 | clinicaltrials |
| NCT04822805 | A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma | unknown | Phase 2 | 27 | First People's Hospital of HangzhouOTHER | 1 | Mar 30, 2021 | clinicaltrials |
| NCT04792437 | Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data | unknown | — | 120 | Yu Yao, MDOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT04772846 | Chloroquine for Glioblastoma. | unknown | Phase 1 / Phase 2 | 60 | Egyptian Medical SyndicateOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04216537 | Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas | unknown | — | 3,000 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT04216550 | Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas | unknown | — | 600 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT04220424 | Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis | unknown | — | 500 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT03941626 | Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies | unknown | Phase 1 / Phase 2 | 50 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Feb 4, 2021 | clinicaltrials |
| NCT03258021 | TTFields In GErmany in Routine Clinical Care(TIGER) | unknown | — | 710 | NovoCure Ltd.INDUSTRY | 1 | Jan 28, 2021 | clinicaltrials |
| NCT02904525 | Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model(XENOGBM) | unknown | N/A | 20 | Andreas HottingerOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04588454 | 18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme(PSMA-GBM) | unknown | N/A | 5 | Radboud University Medical CenterOTHER | 1 | Jan 27, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Aug 10, 2022source: clinicaltrials